ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Smi Drug Discovery Limited

Smi Drug Discovery Limited is an active company incorporated on 29 January 2018 with the registered office located in Cambridge, Cambridgeshire. Smi Drug Discovery Limited was registered 7 years ago.
Status
Active
Active since 6 years ago
Company No
11175710
Private limited company
Age
7 years
Incorporated 29 January 2018
Size
Small
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Submitted
Dated 6 January 2025 (9 months ago)
Next confirmation dated 6 January 2026
Due by 20 January 2026 (2 months remaining)
Last change occurred 9 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
23 Longmeadow
Lode
Cambridge
CB25 9HA
United Kingdom
Address changed on 13 Jan 2022 (3 years ago)
Previous address was 23 Longmeadow Longmeadow Lode Cambridge CB25 9HA United Kingdom
Telephone
Unreported
Email
Available in Endole App
People
Officers
4
Shareholders
11
Controllers (PSC)
1
Director • Chief Executive Officer • British • Lives in UK • Born in Jun 1973
Director • British • Lives in England • Born in Aug 1952
Director • Scientist • British • Lives in England • Born in Jan 1957
Director • Chief Financial Officer • British • Lives in England • Born in Jan 1973
Norcliffe Nominees Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Biocaptiva Limited
Stephen Little is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2019–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£668.81K
Increased by £184.71K (+38%)
Turnover
Unreported
Same as previous period
Employees
13
Increased by 1 (+8%)
Total Assets
£1.22M
Increased by £323.6K (+36%)
Total Liabilities
-£86.61K
Increased by £6.43K (+8%)
Net Assets
£1.13M
Increased by £317.17K (+39%)
Debt Ratio (%)
7%
Decreased by 1.85% (-21%)
Latest Activity
Full Accounts Submitted
6 Months Ago on 15 Apr 2025
Andrew James Thompson (PSC) Resigned
6 Months Ago on 3 Apr 2025
Confirmation Submitted
9 Months Ago on 14 Jan 2025
Andrew James Thompson (PSC) Details Changed
11 Months Ago on 28 Nov 2024
Full Accounts Submitted
1 Year Ago on 30 Sep 2024
Confirmation Submitted
1 Year 9 Months Ago on 17 Jan 2024
Norcliffe Nominees Limited (PSC) Details Changed
2 Years 1 Month Ago on 28 Sep 2023
Full Accounts Submitted
2 Years 3 Months Ago on 31 Jul 2023
Norcliffe Nominees Limited (PSC) Appointed
3 Years Ago on 1 Feb 2022
Andrew James Thompson (PSC) Details Changed
3 Years Ago on 1 Feb 2022
Get Credit Report
Discover Smi Drug Discovery Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 26 September 2025
Submitted on 29 Sep 2025
Cessation of Andrew James Thompson as a person with significant control on 3 April 2025
Submitted on 24 Sep 2025
Statement of capital following an allotment of shares on 9 September 2025
Submitted on 10 Sep 2025
Statement of capital following an allotment of shares on 8 September 2025
Submitted on 10 Sep 2025
Statement of capital following an allotment of shares on 27 June 2025
Submitted on 27 Jun 2025
Statement of capital following an allotment of shares on 19 June 2025
Submitted on 20 Jun 2025
Total exemption full accounts made up to 31 December 2024
Submitted on 15 Apr 2025
Statement of capital following an allotment of shares on 3 April 2025
Submitted on 4 Apr 2025
Change of details for Andrew James Thompson as a person with significant control on 28 November 2024
Submitted on 14 Jan 2025
Confirmation statement made on 6 January 2025 with updates
Submitted on 14 Jan 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year